| Epidermal growth factor enemas with oral mesalamine for mild-to-moderate left-sided ulcerative colitis or proctitis A Sinha, JMD Nightingale, KP West, J Berlanga-Acosta, RJ Playford New England Journal of Medicine 349 (4), 350-357, 2003 | 376 | 2003 |
| The pro‐inflammatory environment in recalcitrant diabetic foot wounds JB Acosta, D Garcia del Barco, D Cibrian Vera, W Savigne, ... International wound journal 5 (4), 530-539, 2008 | 230 | 2008 |
| Intra‐lesional injections of recombinant human epidermal growth factor promote granulation and healing in advanced diabetic foot ulcers: multicenter, randomised, placebo … JI Fernández‐Montequín, CM Valenzuela‐Silva, OG Díaz, W Savigne, ... International wound journal 6 (6), 432-443, 2009 | 209 | 2009 |
| Epidermal growth factor in clinical practice–a review of its biological actions, clinical indications and safety implications J Berlanga‐Acosta, J Gavilondo‐Cowley, P López‐Saura, ... International wound journal 6 (5), 331-346, 2009 | 184 | 2009 |
| Intralesional administration of epidermal growth factor‐based formulation (Heberprot‐P) in chronic diabetic foot ulcer: treatment up to complete wound closure JI Fernández‐Montequín, BY Betancourt, G Leyva‐Gonzalez, EL Mola, ... International wound journal 6 (1), 67-72, 2009 | 178 | 2009 |
| Intralesional injections of Citoprot‐P® (recombinant human epidermal growth factor) in advanced diabetic foot ulcers with risk of amputation JI Fernández‐Montequín, E Infante‐Cristiá, C Valenzuela‐Silva, ... International Wound Journal 4 (4), 333-343, 2007 | 166 | 2007 |
| Glucose toxic effects on granulation tissue productive cells: the diabetics’ impaired healing J Berlanga-Acosta, GS Schultz, E López-Mola, G Guillen-Nieto, ... BioMed research international 2013, 2013 | 146 | 2013 |
| Epidermal growth factor intralesional infiltrations can prevent amputation in patients with advanced diabetic foot wounds JB Acosta, W Savigne, C Valdez, N Franco, JS Alba, A Rio, ... International wound journal 3 (3), 232-239, 2006 | 113 | 2006 |
| Gastrointestinal cell proliferation and crypt fission are separate but complementary means of increasing tissue mass following infusion of epidermal growth factor in rats J Berlanga-Acosta, RJ Playford, N Mandir, RA Goodlad Gut 48 (6), 803-807, 2001 | 94 | 2001 |
| Diabetic foot ulcers and epidermal growth factor: revisiting the local delivery route for a successful outcome J Berlanga-Acosta, J Fernández-Montequín, C Valdés-Pérez, ... BioMed research international 2017, 2017 | 91 | 2017 |
| Diabetic lower extremity wounds: the rationale for growth factors‐based infiltration treatment J Berlanga‐Acosta International wound journal 8 (6), 612-620, 2011 | 85 | 2011 |
| Healing enhancement of diabetic wounds by locally infiltrated epidermal growth factor is associated with systemic oxidative stress reduction AG Ojalvo, JB Acosta, YM Marí, MF Mayola, CV Pérez, WS Gutiérrez, ... International wound journal 14 (1), 214-225, 2017 | 76 | 2017 |
| Cellular senescence as the pathogenic hub of diabetes-related wound chronicity JA Berlanga-Acosta, GE Guillén-Nieto, N Rodríguez-Rodríguez, ... Frontiers in Endocrinology 11, 573032, 2020 | 62 | 2020 |
| Insulin resistance at the crossroad of Alzheimer disease pathology: A review J Berlanga-Acosta, G Guillén-Nieto, N Rodríguez-Rodríguez, ... Frontiers in endocrinology 11, 560375, 2020 | 55 | 2020 |
| Wound chronicity, impaired immunity and infection in diabetic patients N Rodríguez-Rodríguez, I Martínez-Jiménez, A García-Ojalvo, ... MEDICC review 24, 44-58, 2022 | 51 | 2022 |
| Potency and stability of C terminal truncated human epidermal growth factor DP Calnan, A Fagbemi, J Berlanga-Acosta, T Marchbank, T Sizer, ... Gut 47 (5), 622-627, 2000 | 50 | 2000 |
| Epidermal growth factor (EGF) and platelet-derived growth factor (PDGF) as tissue healing agents: clarifying concerns about their possible role in malignant transformation and … J Berlanga-Acosta, J Gavilondo-Cowley, DG del Barco-Herrera, ... J Carcinogene Mutagene 2 (1), 100-15, 2011 | 40 | 2011 |
| Systemic translation of locally infiltrated epidermal growth factor in diabetic lower extremity wounds A García‐Ojalvo, J Berlanga Acosta, A Figueroa‐Martínez, ... International Wound Journal 16 (6), 1294-1303, 2019 | 38 | 2019 |
| Intestinal growth in parenterally‐fed rats induced by the combined effects of glucagon‐like peptide 2 and epidermal growth factor PA Kitchen, RA Goodlad, AJ FitzGerald, N Mandir, MA Ghatei, SR Bloom, ... Journal of Parenteral and Enteral Nutrition 29 (4), 248-254, 2005 | 38 | 2005 |
| Effect of epidermal growth factor administration on intestinal cell proliferation, crypt fission and polyp formation in multiple intestinal neoplasia (Min) mice O Bashir, AJ Fitzgerald, J Berlanga-Acosta, RJ Playford, RA Goodlad Clinical science 105 (3), 323-330, 2003 | 36 | 2003 |
